Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

P D Kroboth

Showing results (31-40 of 56) with videos related to

Pageof 6
Sort By:
Archives of Internal Medicine|June 1, 1983
Hearing loss and erythromycin pharmacokinetics in a patient receiving hemodialysisP D Kroboth, M A McNeil, A Kreeger, et al.
Journal of Clinical Psychopharmacology|February 1, 2000
Clonazepam and sertraline: absence of drug interaction in a multiple-dose studyP L Bonate, P D Kroboth, R B Smith, et al.
Journal of Clinical Pharmacology|August 1, 1987
Nighttime dosing of triazolam in patients with liver disease and normal subjects: kinetics and daytime effectsP D Kroboth, R B Smith, D H Van Thiel, et al.
Antimicrobial Agents and Chemotherapy|January 1, 1982
Pharmacokinetics of single-dose erythromycin in normal and alcoholic liver disease subjectsP D Kroboth, A Brown, J A Lyon, et al.
Journal of Clinical Pharmacology|April 10, 1999
DHEA and DHEA-S: a reviewP D Kroboth, F S Salek, A L Pittenger, et al.
Journal of Clinical Psychopharmacology|August 1, 1995
Triazolam pharmacokinetics after intravenous, oral, and sublingual administrationP D Kroboth, J W McAuley, F J Kroboth, et al.
Journal of Clinical Psychopharmacology|February 1, 1995
Orally administered progesterone enhances sensitivity to triazolam in postmenopausal womenJ W McAuley, I J Reynolds, F J Kroboth, et al.
International Journal of Clinical Pharmacology, Therapy, and Toxicology|September 1, 1993
Design and pharmacodynamic evaluation of novel dual release formulations of triazolamR B Smith, P D Kroboth, M M Folan, et al.
Journal of Clinical Psychopharmacology|April 22, 1999
Alprazolam increases dehydroepiandrosterone concentrationsP D Kroboth, F S Salek, R A Stone, et al.
Psychopharmacology|January 1, 1984
Pharmacokinetics and pharmacodynamics of alprazolam after oral and IV administrationR B Smith, P D Kroboth, J T Vanderlugt, et al.
Pageof 6

Showing results (31-40 of 56) with videos related to

Sort By:
Pageof 6
Archives of Internal Medicine|June 1, 1983
Hearing loss and erythromycin pharmacokinetics in a patient receiving hemodialysisP D Kroboth, M A McNeil, A Kreeger, et al.
Journal of Clinical Psychopharmacology|February 1, 2000
Clonazepam and sertraline: absence of drug interaction in a multiple-dose studyP L Bonate, P D Kroboth, R B Smith, et al.
Journal of Clinical Pharmacology|August 1, 1987
Nighttime dosing of triazolam in patients with liver disease and normal subjects: kinetics and daytime effectsP D Kroboth, R B Smith, D H Van Thiel, et al.
Antimicrobial Agents and Chemotherapy|January 1, 1982
Pharmacokinetics of single-dose erythromycin in normal and alcoholic liver disease subjectsP D Kroboth, A Brown, J A Lyon, et al.
Journal of Clinical Pharmacology|April 10, 1999
DHEA and DHEA-S: a reviewP D Kroboth, F S Salek, A L Pittenger, et al.
Journal of Clinical Psychopharmacology|August 1, 1995
Triazolam pharmacokinetics after intravenous, oral, and sublingual administrationP D Kroboth, J W McAuley, F J Kroboth, et al.
Journal of Clinical Psychopharmacology|February 1, 1995
Orally administered progesterone enhances sensitivity to triazolam in postmenopausal womenJ W McAuley, I J Reynolds, F J Kroboth, et al.
International Journal of Clinical Pharmacology, Therapy, and Toxicology|September 1, 1993
Design and pharmacodynamic evaluation of novel dual release formulations of triazolamR B Smith, P D Kroboth, M M Folan, et al.
Journal of Clinical Psychopharmacology|April 22, 1999
Alprazolam increases dehydroepiandrosterone concentrationsP D Kroboth, F S Salek, R A Stone, et al.
Psychopharmacology|January 1, 1984
Pharmacokinetics and pharmacodynamics of alprazolam after oral and IV administrationR B Smith, P D Kroboth, J T Vanderlugt, et al.
Pageof 6